Funding health benefits for a growing biotech employer
A biotech adding staff quickly moves from a tiny group to a mid-size one in a few years. The right funding model changes along the way, and the plan should anticipate it.
Six funding stages for a growing biotech.
Fully Insured for the Earliest Stage
Small groups usually start fully insured, which is simple and predictable.
Level-Funded as the Group Grows
Level-funding can reduce cost for a healthy, growing group while capping exposure.
Self-Funding at Scale
Larger groups may self-fund, with stop-loss, once claims are predictable enough.
Stop-Loss Terms for a Young Workforce
Young groups can have low claims, but a single large claim has outsized effect.
Triggers for Changing Models
Define headcount, claims and cash-flow signals that signal a change.
Pharmacy and Specialty Drug Exposure
Specialty drug use, even by one person, can change the picture.
Mapping the funding path ahead of time.
The funding model that fits a ten-person biotech seldom fits one with eighty. Writing down the triggers in advance, such as headcount, stable claims history and cash position, lets the company move at the right moment and not too early or too late.
Specialty drugs deserve their own thought. A single employee on a high-cost therapy can change a small group’s experience significantly, so the stop-loss terms and pharmacy contract should be reviewed with that possibility in mind. A young workforce usually means low claims on average, but the average is not what causes the surprise.
Funding questions from growing biotech employers.
Plain answers for HR, finance and deal teams.
Which Funding Model Is Best for a Biotech?
It depends on size, claims and cash. Many start fully insured and move toward level-funded or self-funded as they grow.
When Is a Company Large Enough to Self-Fund?
There is no fixed number. Claims stability, cash position and stop-loss availability decide.
What Is the Risk in Moving Away From Fully Insured?
Claims can exceed expectations. Stop-loss limits the downside but does not remove it.
How Does Growth Affect Renewal?
A fast-growing group can see renewal pricing shift as demographics and claims change.
Can We Switch Back?
Sometimes. It is easier to move toward more risk than away from it, so decisions are made carefully.
What Do Investors Want to See?
Predictable cost and clean compliance. A funding model that is easy to explain helps in diligence.
How Do Young Employees Affect Cost?
Younger groups often have lower average claims, but they also bring pregnancy and family costs.
Does Location Matter?
Yes. Carrier availability and pricing differ by county and state.
How Do We Plan for a Large Claim?
With stop-loss selected for the company’s cash tolerance, and a plan for an unexpected spike.
What Is in the Funding Roadmap?
A funding roadmap tied to growth stages, with the triggers for each change.
When does level-funding make sense?
When the group is large enough to be underwritten on its own experience, is likely to be healthy and wants more cost control than fully insured offers, while keeping risk capped.
What should we watch to know it is time to change funding?
Headcount, a year or more of stable claims, cash flow comfort with variation and the pricing gap between funding options at renewal.
Ready? Upload your renewal, or talk it through with someone first. No cost, no obligation.
General information about a funding roadmap, not legal or tax advice. Plan-specific questions belong with your counsel and tax advisor, and we will bring them in.
Related reading on funding as you grow.
Biotech Funding Overview
The page this belongs to.
Hub for Life Sciences Topics
The full section.
Health Plan Funding Options Compared
How funding models differ.
Planning for growth? Send us the headcount plan.
We’ll tell you whether it looks competitive, where we see opportunity, and the five questions we’d put to your carrier. No cost, and no obligation to move anything.
The renewal letter
Your current plan summary
Contribution split by tier
Enrolled counts by tier
Four documents, two more if your group is 50 or more. Nothing else; every extra one is a reason to postpone.
An independent employee benefits consulting firm. We look at the entire benefits program — cost, plan performance, risk and administration.
Switch to CFH. Unhappy with your broker? Your employees won’t notice. You will. →